← Back to Search

Exercise Strategy for Cancer Survivors (ACCESS Trial)

N/A

Recruiting

Research Sponsored by Nova Scotia Health Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be 18+ years

Be pre-treatment, receiving active treatment, or have received cancer treatment within the past 5 years or have late presenting/ongoing side-effects related to the cancer diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

ACCESS Trial Summary

This trialwill test ways to help cancer survivors live longer, healthier lives by exercising and managing physical/mental health effects of cancer.

Who is the study for?

This trial is for adults over 18 who have been diagnosed with cancer, whether they're about to start treatment, currently in treatment, or finished within the last 5 years. Participants should be able to do light exercise and commit to a 12-week program in Halifax.Check my eligibility

What is being tested?

The ACCESS program aims to integrate exercise as part of cancer care. It tests how effective a structured 12-week exercise regimen can be in improving physical and psychological health outcomes for cancer survivors.See study design

What are the potential side effects?

Since this trial involves physical activity tailored for cancer survivors, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue but will vary based on individual health conditions.

ACCESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am currently undergoing, or have undergone cancer treatment within the last 5 years, or I am experiencing ongoing side-effects from the treatment.

ACCESS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Daily steps

Depression Anxiety Stress Scales (DASS)

Fatigue

+11 more

ACCESS Trial Design

1Treatment groups

Experimental Treatment

Group I: ACCESSExperimental Treatment1 Intervention

Individuals that consent to the study will be assigned to a 12-week exercise program (ACCESS)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise

2016

Completed Phase 1

~760

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor

258 Previous Clinical Trials

83,754 Total Patients Enrolled

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT03599843 — N/A

Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT03599843 — N/A

Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT03599843 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies for participants in the clinical trial?

"This medical trial is actively seeking participants; the listing was initially created on September 1st 2018 and has been amended recently, on February 7th 2023."

Answered by AI

What is the total sample size for this experiment?

"Yes, the clinicaltrials.gov database reflects that this research project is currently in need of participants. It first appeared on September 1st 2018 and was modified most recently on February 7th 2023. The study aims to include 100 individuals at a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Activating Cancer Communities Through an Exercise Strategy for Survivors

Scott Grandy 2018. "Activating Cancer Communities Through an Exercise Strategy for Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03599843.